Clinical Trial Update: A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C [NA]

View source ↗

Summary

A terminated pilot study evaluated high-dose intravenous vitamin C as a treatment for hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ascorbic acid (Vitamin C) (ascorbic acid)

Snippet

Sponsor: Health Innovations, Frontier Research Institute | Conditions: Hepatitis C | NA | Status: TERMINATED